After 15 Years of Failure, What Can Pharma Offer Alzheimer’s Patients?
from The Pharma Letter
As patients, physicians and pharma firms digest the latest research, presented at last week’s Alzheimer’s Association International Conference (AAIC), what can the pharmaceutical industry offer the estimated 50 million people living with this most burdensome of conditions?
Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.